1 |
Takayanagi H. : Osteoimmunology: shared mechanismsand crosstalk between the immun and bone systems. Nat. Rev. Immunol. 7, 292 (2007).
DOI
ScienceOn
|
2 |
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J. and Suda, T. : Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600 (1988).
DOI
ScienceOn
|
3 |
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. : Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345 (1999).
DOI
|
4 |
Humphrey, M. B., Lanier, L. L. and Nakamura, M. C. : Role of ITAM-containing adaptor proteins and their receptors in the immune system and bone. Immunol. Rev. 208, 50 (2005).
DOI
ScienceOn
|
5 |
Masishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J. and Shan, B. : Identification of a nuclear receptor for bile acid. Science 284, 1362 (1999).
DOI
ScienceOn
|
6 |
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. and Schoonjans, K. : Targeting bile acid signalling for metabolic diseases. Nat. Rev. Drug. Discov. 7, 678 (2008).
DOI
ScienceOn
|
7 |
Huang, L., Sun, Y., Zhu, H., Zhang, Y., Xu, J. and Shen, Y. M. : Synthesis and antimicrobial evaluation of bile acid tridentate conjugates. Steroids 74, 701 (2009).
DOI
ScienceOn
|
8 |
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D. and Lehmann, J. M. : Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365 (1999).
DOI
|
9 |
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. and Steals, B. : Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89, 147 (2009).
DOI
ScienceOn
|
10 |
Cho, S. W., An, J. H., Park, H., Yang, J. Y., Choi, H. J., Kim, S. W., Park, Y. J., Kim, S. Y., Yim, M., Baek, W. Y., Kim, J. E. and Shin, C. S. : Positive regulation of osteogenesis by bile acid through FXR. J. Bone. Miner. Res. 28, 2109 (2013).
DOI
|
11 |
Bortolini, O., Fantin, G., Fogagnolo, M., Rossetti, S., Maiuolo, L., Di Pompo, G., Avnet, S. and Granchi, D. : Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids. Eur. J. Med. Chem. 52, 221 (2012).
DOI
ScienceOn
|
12 |
Wong, S. C., Chan, J. K., Lee, K. C. and Hsiao, W. L. : Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J. Pathol. 194, 35 (2001).
DOI
ScienceOn
|
13 |
Stacey, D. W. : Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell. Biol. 15, 158 (2003).
DOI
ScienceOn
|
14 |
Jennifer, M. C., Tim, D. E., Ryan, D. R., Yijie, W., Nabendu, P., Amit, M. and Clay, B. M. : M-CSF Signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE 3, e3405 (2008).
DOI
ScienceOn
|
15 |
Coqueret, O. : New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell. Biol. 13, 65 (2003).
DOI
ScienceOn
|
16 |
Thomas, F. F., Christoph, P. H., Lisa, S., Grigoriy, A. S. and Chizuru, S. : PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983 (2003).
DOI
ScienceOn
|